136 related articles for article (PubMed ID: 30902657)
1. Farnesoid X receptor agonist GW4064 indirectly inhibits HCV entry into cells via down-regulating scavenger receptor class B type I.
Wu ZY; Li H; Li JR; Lv XQ; Jiang JD; Peng ZG
Eur J Pharmacol; 2019 Jun; 853():111-120. PubMed ID: 30902657
[TBL] [Abstract][Full Text] [Related]
2. FXR agonist GW4064 increases plasma glucocorticoid levels in C57BL/6 mice.
Hoekstra M; van der Sluis RJ; Li Z; Oosterveer MH; Groen AK; Van Berkel TJ
Mol Cell Endocrinol; 2012 Oct; 362(1-2):69-75. PubMed ID: 22643070
[TBL] [Abstract][Full Text] [Related]
3. FXR agonist GW4064 alleviates endotoxin-induced hepatic inflammation by repressing macrophage activation.
Yao J; Zhou CS; Ma X; Fu BQ; Tao LS; Chen M; Xu YP
World J Gastroenterol; 2014 Oct; 20(39):14430-41. PubMed ID: 25339829
[TBL] [Abstract][Full Text] [Related]
4. Reciprocal regulation of farnesoid X receptor α activity and hepatitis B virus replication in differentiated HepaRG cells and primary human hepatocytes.
Radreau P; Porcherot M; Ramière C; Mouzannar K; Lotteau V; André P
FASEB J; 2016 Sep; 30(9):3146-54. PubMed ID: 27251172
[TBL] [Abstract][Full Text] [Related]
5. Dual Agonist of Farnesoid X Receptor and Takeda G Protein-Coupled Receptor 5 Inhibits Hepatitis B Virus Infection In Vitro and In Vivo.
Ito K; Okumura A; Takeuchi JS; Watashi K; Inoue R; Yamauchi T; Sakamoto K; Yamashita Y; Iguchi Y; Une M; Wakita T; Umezawa K; Yoneda M
Hepatology; 2021 Jul; 74(1):83-98. PubMed ID: 33434356
[TBL] [Abstract][Full Text] [Related]
6. Adiponectin determines farnesoid X receptor agonism-mediated cardioprotection against post-infarction remodelling and dysfunction.
Xia Y; Zhang F; Zhao S; Li Y; Chen X; Gao E; Xu X; Xiong Z; Zhang X; Zhang J; Zhao H; Wang W; Wang H; Guo Y; Liu Y; Li C; Wang S; Zhang L; Yan W; Tao L
Cardiovasc Res; 2018 Aug; 114(10):1335-1349. PubMed ID: 29668847
[TBL] [Abstract][Full Text] [Related]
7. Knockdown of ATP8B1 expression leads to specific downregulation of the bile acid sensor FXR in HepG2 cells: effect of the FXR agonist GW4064.
Martínez-Fernández P; Hierro L; Jara P; Alvarez L
Am J Physiol Gastrointest Liver Physiol; 2009 May; 296(5):G1119-29. PubMed ID: 19228886
[TBL] [Abstract][Full Text] [Related]
8. CD36 is a co-receptor for hepatitis C virus E1 protein attachment.
Cheng JJ; Li JR; Huang MH; Ma LL; Wu ZY; Jiang CC; Li WJ; Li YH; Han YX; Li H; Chen JH; Wang YX; Song DQ; Peng ZG; Jiang JD
Sci Rep; 2016 Feb; 6():21808. PubMed ID: 26898231
[TBL] [Abstract][Full Text] [Related]
9. Farnesoid X receptor agonists attenuate colonic epithelial secretory function and prevent experimental diarrhoea in vivo.
Mroz MS; Keating N; Ward JB; Sarker R; Amu S; Aviello G; Donowitz M; Fallon PG; Keely SJ
Gut; 2014 May; 63(5):808-17. PubMed ID: 23916961
[TBL] [Abstract][Full Text] [Related]
10. Fragmentation of GW4064 led to a highly potent partial farnesoid X receptor agonist with improved drug-like properties.
Flesch D; Gabler M; Lill A; Gomez RC; Steri R; Schneider G; Stark H; Schubert-Zsilavecz M; Merk D
Bioorg Med Chem; 2015 Jul; 23(13):3490-8. PubMed ID: 25934227
[TBL] [Abstract][Full Text] [Related]
11. Farnesoid X receptor agonists suppress hepatic apolipoprotein CIII expression.
Claudel T; Inoue Y; Barbier O; Duran-Sandoval D; Kosykh V; Fruchart J; Fruchart JC; Gonzalez FJ; Staels B
Gastroenterology; 2003 Aug; 125(2):544-55. PubMed ID: 12891557
[TBL] [Abstract][Full Text] [Related]
12. Restoration of enterohepatic bile acid pathways in pregnant mice following short term activation of Fxr by GW4064.
Moscovitz JE; Kong B; Buckley K; Buckley B; Guo GL; Aleksunes LM
Toxicol Appl Pharmacol; 2016 Nov; 310():60-67. PubMed ID: 27609522
[TBL] [Abstract][Full Text] [Related]
13. Substituted isoxazole analogs of farnesoid X receptor (FXR) agonist GW4064.
Bass JY; Caldwell RD; Caravella JA; Chen L; Creech KL; Deaton DN; Madauss KP; Marr HB; McFadyen RB; Miller AB; Parks DJ; Todd D; Williams SP; Wisely GB
Bioorg Med Chem Lett; 2009 Jun; 19(11):2969-73. PubMed ID: 19410460
[TBL] [Abstract][Full Text] [Related]
14. Synthetic FXR agonist GW4064 is a modulator of multiple G protein-coupled receptors.
Singh N; Yadav M; Singh AK; Kumar H; Dwivedi SK; Mishra JS; Gurjar A; Manhas A; Chandra S; Yadav PN; Jagavelu K; Siddiqi MI; Trivedi AK; Chattopadhyay N; Sanyal S
Mol Endocrinol; 2014 May; 28(5):659-73. PubMed ID: 24597548
[TBL] [Abstract][Full Text] [Related]
15. Glucocorticosteroids increase cell entry by hepatitis C virus.
Ciesek S; Steinmann E; Iken M; Ott M; Helfritz FA; Wappler I; Manns MP; Wedemeyer H; Pietschmann T
Gastroenterology; 2010 May; 138(5):1875-84. PubMed ID: 20152835
[TBL] [Abstract][Full Text] [Related]
16. Farnesoid X Receptor Agonist GW4064 Inhibits Aromatase and ERβ Expression in Human Endometriotic Stromal Cells.
Wu PL; Zeng C; Zhou YF; Yin L; Yu XL; Xue Q
Reprod Sci; 2019 Aug; 26(8):1111-1120. PubMed ID: 30428773
[TBL] [Abstract][Full Text] [Related]
17. Synthesis of Novel Farnesoid X Receptor Agonists and Validation of Their Efficacy in Activating Differentiation of Mouse Bone Marrow-Derived Mesenchymal Stem Cells into Osteoblasts.
Fujimori K; Iguchi Y; Yamashita Y; Gohda K; Teno N
Molecules; 2019 Nov; 24(22):. PubMed ID: 31744088
[TBL] [Abstract][Full Text] [Related]
18. Unbinding pathways of GW4064 from human farnesoid X receptor as revealed by molecular dynamics simulations.
Li W; Fu J; Cheng F; Zheng M; Zhang J; Liu G; Tang Y
J Chem Inf Model; 2012 Nov; 52(11):3043-52. PubMed ID: 23101941
[TBL] [Abstract][Full Text] [Related]
19. Novel heterocyclic scaffolds of GW4064 as farnesoid X receptor agonists.
Smalley TL; Boggs S; Caravella JA; Chen L; Creech KL; Deaton DN; Kaldor I; Parks DJ
Bioorg Med Chem Lett; 2015 Jan; 25(2):280-4. PubMed ID: 25499883
[TBL] [Abstract][Full Text] [Related]
20. GW4064, a farnesoid X receptor agonist, upregulates adipokine expression in preadipocytes and HepG2 cells.
Xin XM; Zhong MX; Yang GL; Peng Y; Zhang YL; Zhu W
World J Gastroenterol; 2014 Nov; 20(42):15727-35. PubMed ID: 25400456
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
